Home » Authors » Trista Morrison

Articles by Trista Morrison

Soaring on Swine Flu Data, Inovio Prices $30M Offering

July 31, 2009

By Trista Morrison

NewCo News: Mutant Genome Sentinel p53: Oncoceutics May Repair You

July 30, 2009

By Trista Morrison

Ridaforolimus Combo Data, Buyout Rumors Boost Ariad

July 29, 2009

By Trista Morrison

More Action in the Tools Space: Agilent Buying Varian for $1.5B

July 28, 2009

By Trista Morrison

Orexigen Data Highlight Glut of Partnering Options in Obesity

July 27, 2009

By Trista Morrison

NewCo News: Intellikine Moves into Busy P13K Space with Tricks Up Its Sleeve

July 27, 2009

By Trista Morrison

Phase III Obesity Data in Hand, Orexigen Prices $75M Offering

July 24, 2009

By Trista Morrison

Gilead Meets Quarterly Estimates Thanks Again to HIV Franchise

July 23, 2009

By Trista Morrison

Orexigen Clears Phase III Hurdle, But Battle of the Bulge Not Over

July 21, 2009

By Trista Morrison

ACS: Drugs Tumble Forth, But No Cancer War Victory

July 20, 2009

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...